GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
37.70 +0.27  +0.72% NYSE Dec 2, 20:00 Delayed 2m USD

GlaxoSmithKline Return on Equity (TTM):

7.29% for Sept. 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

GlaxoSmithKline Return on Equity (TTM) Chart

Export Data
Save Image
Print Image

GlaxoSmithKline Historical Return on Equity (TTM) Data

View and export this data going back to 1985. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2016 7.29%
June 30, 2016 1.21%
March 31, 2016 11.17%
Dec. 31, 2015 144.7%
Sept. 30, 2015 167.0%
June 30, 2015 157.4%
March 31, 2015 165.7%
Dec. 31, 2014 47.18%
Sept. 30, 2014 67.48%
June 30, 2014 73.38%
March 31, 2014 78.57%
Dec. 31, 2013 84.95%
Sept. 30, 2013 60.73%
June 30, 2013 61.61%
March 31, 2013 60.09%
Dec. 31, 2012 62.71%
Sept. 30, 2012 64.76%
June 30, 2012 64.56%
March 31, 2012 59.85%
Dec. 31, 2011 63.04%
Sept. 30, 2011 38.76%
June 30, 2011 36.37%
March 31, 2011 19.81%
Dec. 31, 2010 17.02%
Sept. 30, 2010 41.51%
   
June 30, 2010 44.42%
March 31, 2010 64.14%
Dec. 31, 2009 65.06%
Sept. 30, 2009 59.16%
June 30, 2009 57.23%
March 31, 2009 55.32%
Dec. 31, 2008 56.15%
Sept. 30, 2008 54.22%
June 30, 2008 53.17%
March 31, 2008 51.19%
Dec. 31, 2007 52.72%
Sept. 30, 2007 54.25%
June 30, 2007 56.31%
March 31, 2007 59.06%
Dec. 31, 2006 62.17%
Sept. 30, 2006 65.07%
June 30, 2006 66.90%
March 31, 2006 71.50%
Dec. 31, 2005 73.36%
Sept. 30, 2005 71.25%
June 30, 2005 71.70%
March 31, 2005 73.96%
Dec. 31, 2004 67.50%
Sept. 30, 2004 65.69%
June 30, 2004 63.34%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Return on Equity (ROE)

Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).

ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.

Investors generally are interested in company's that have high, increasing returns on equity.
Learn More

Advertisement

GSK Return on Equity (TTM) Benchmarks

Companies
Johnson & Johnson 21.88%
Pfizer 9.64%
Merck & Co 12.41%

GSK Return on Equity (TTM) Range, Past 5 Years

Minimum 1.21% Jun 2016
Maximum 167.0% Sep 2015
Average 75.17%

GSK Return on Equity (TTM) Excel Add-In Codes

  • Metric Code: return_on_equity
  • Latest data point: =YCP("GSK", "return_on_equity")
  • Last 5 data points: =YCS("GSK", "return_on_equity", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.